Fundraising Fox
Matthew Roden
InvestorEntrepreneur Partner at MPM BioImpact
Find your path to Matthew
Sign up to see every warm intro you have to Matthew
- Paths you didn't know you had: your email and LinkedIn already hold routes to Matthew. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Entrepreneur Partner and CEO of portfolio company Aktis Oncology; formerly SVP and Head of Enterprise Strategy at Bristol Myers Squibb and Head of Biotech Equity Research at UBS. Holds a Ph.D. from Albert Einstein College of Medicine.
Colleagues at MPM BioImpact
Alan Kelly
Director at MPM BioImpact
Andrew M. Scharenberg
Entrepreneur Partner at MPM BioImpact
Ansbert Gadicke
Managing Partner at MPM BioImpact
Ansbert Gadicke, M.D.
Chairman at MPM BioImpact
Aparna Parikh
Entrepreneur Partner at MPM BioImpact
Bard Geesaman
Managing Partner at MPM Capital
Binsen Li
Principal at MPM BioImpact
Brendan Furey
Chief Compliance Officer at MPM BioImpact
Frequently asked questions
- Who is Matthew Roden?
- Entrepreneur Partner and CEO of portfolio company Aktis Oncology; formerly SVP and Head of Enterprise Strategy at Bristol Myers Squibb and Head of Biotech Equity Research at UBS. Holds a Ph.D. from Albert Einstein College of Medicine.
- Where does Matthew Roden work?
- Matthew Roden is Entrepreneur Partner at MPM BioImpact.
About this profile. Compiled from public sources — MPM BioImpact's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights